Even if WTO waives IP on vaccines, India will face challenge translating this into mass production The barriers are more practical than legal. A Mumbai vaccination centre runs out of stocks. | Punit Paranjpe/AFP jointly submitted by India and South Africa at the World Trade Organisation, the European Union remains the last major power opposing this proposal. While we await the results of possibly lengthy text-based negotiations, it is necessary for the government of India to come out with a white paper explaining how exactly it intends to operationalise a possible IP waiver for vaccines, if and when such a waiver comes into effect.